SCHEMBL659016

SCHEMBL659016

CC(C)(C)Sc1c(Br)cc(F)cc1/C=N/O

nearest known ligand 0.33

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.33
MAPT P10636 3/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HPGD P15428 5/20 0.31
TSHR P16473 1/20 0.31
HTT P42858 2/20 0.30
ALOX15 P16050 1/20 0.30
HSD17B10 Q99714 1/20 0.30
ALOX12 P18054 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30
CYP2D6 P10635 1/20 0.30
CYP2C9 P11712 1/20 0.30
CYP2C19 P33261 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL659017 1.00 ALDH1A1 (0.33) ALDH1A1MAPTMEN1KMT2AL3MBTL1
SCHEMBL660309 0.80 ERN1 (0.37)
SCHEMBL659677 0.77 KMT2A (0.44) ALDH1A1MAPTMEN1KMT2AL3MBTL1
SCHEMBL659676 0.77 KMT2A (0.44) ALDH1A1MAPTMEN1KMT2AL3MBTL1
SCHEMBL30127063 0.76 ALDH1A1 (0.33) ALDH1A1MAPTMEN1KMT2AL3MBTL1
SCHEMBL660820 0.75 ALOX12 (0.45) ALDH1A1MAPTMEN1KMT2AL3MBTL1
SCHEMBL660821 0.75 ALOX12 (0.45) ALDH1A1MAPTMEN1KMT2AL3MBTL1
SCHEMBL17769218 0.74 HPGD (0.37) ALDH1A1MAPTMEN1KMT2AL3MBTL1
SCHEMBL17769216 0.74 HPGD (0.37) ALDH1A1MAPTMEN1KMT2AL3MBTL1
SCHEMBL29495242 0.74 HPGD (0.37) ALDH1A1MAPTMEN1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8378104-B2 7-aminofuropyridine derivatives OSI Pharmaceuticals, LLC (US) 2013-02-19 US disclosed
US-20120046267-A1 7-AMINOFUROPYRIDINE DERIVATIVES OSI PHARMACEUTICALS, INC. 2012-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046267-A1 7-AMINOFUROPYRIDINE DERIVATIVES MAP3K5, STK17A, MAPKAPK5 ALDH1A1 490/4885MAPT 214/4885MEN1 296/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.